Richard M. Ashworth - 26 Dec 2023 Form 4 Insider Report for AMEDISYS INC (AMED)

Role: President and CEO, Director
Signature: Jennifer Guckert Griffin, pursuant to a power of attorney
Issuer symbol: AMED
Transactions as of: 26 Dec 2023
Net transactions value: -$67,782
Form type: 4
Filing time: 28 Dec 2023, 18:02:56 UTC
Previous filing: 26 Dec 2023
Next filing: 21 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMED	Common Stock	Options Exercise	$896,937	+11,237	+20%	$79.82	67,653	26 Dec 2023	Direct
transaction	AMED	Common Stock	Tax liability	$964,720	-10,140	-15%	$95.14	57,513	26 Dec 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AMED	Stock Option (Right to Buy)	Options Exercise	$0	-11,237	-33%	$0.000000	22,474	26 Dec 2023	Common Stock	11,237	$79.82	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On April 12, 2023, the reporting person was granted 33,711 Stock Options subject to time-based vesting conditions to vest in equal, 1/3 installments on each of February 20, 2024, 2025 and 2026, subject to continued employment. 11,237 of the Stock Options were accelerated from February 2024 to December 21, 2023 in order to mitigate impacts that could arise under Sections 280G and 4999 of the Internal Revenue Code of 1986, as amended. The Reporting Person has signed a letter agreement providing that the shares of common stock underlying such accelerated Stock Options are subject to certain forfeiture conditions. The remaining 22,474 Stock Options are subject to the original vesting terms (half of which will vest on February 20, 2025 and the remaining half will vest on February 20, 2026).

Content

On April 12, 2023, the reporting person was granted 33,711 Stock Options subject to time-based vesting conditions to vest in equal, 1/3 installments on each of February 20, 2024, 2025 and 2026, subject to continued employment. 11,237 of the Stock Options were accelerated from February 2024 to December 21, 2023 in order to mitigate impacts that could arise under Sections 280G and 4999 of the Internal Revenue Code of 1986, as amended. The Reporting Person has signed a letter agreement providing that the shares of common stock underlying such accelerated Stock Options are subject to certain forfeiture conditions. The remaining 22,474 Stock Options are subject to the original vesting terms (half of which will vest on February 20, 2025 and the remaining half will vest on February 20, 2026).